Collaborative Care for Substance Use and Mental Health Disorders
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether a peer-led support system, Peer Supported Collaborative Care, can improve treatment for individuals with both HIV and issues related to substance use or mental health. Participants will be randomly assigned to either continue with their usual HIV care or work with a peer-case manager to address substance use or mental health challenges. The trial aims to determine if added peer support enhances engagement in care and overall management of these conditions. Ideal candidates for this trial are individuals who receive HIV care, have positive screenings for mental health or substance use issues, and are not currently receiving treatment for these conditions. As an unphased trial, this study offers participants a unique opportunity to contribute to innovative care strategies that could enhance their treatment experience.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it requires that participants are not currently receiving treatment for mental health or substance use disorders.
What prior data suggests that this peer-supported collaborative care model is safe for integrating treatment into HIV care settings?
Research has shown that the peer-supported collaborative care model is generally well-received. Studies have found that this approach can improve access to care and treatment outcomes for individuals with mental health and substance use issues. Although specific safety data from clinical trials for this exact setup is lacking, the collaborative care model has been used successfully in various settings without significant reports of harm.
This type of care involves a team, including a peer case manager, to support individuals. It helps manage mental health and substance use disorders by providing ongoing care and support. It is important to understand that this trial does not test a new drug or medical procedure, but rather a care model. Therefore, the safety concerns differ. The aim is to improve the quality and availability of care, not to introduce new medications.12345Why are researchers excited about this trial?
Researchers are excited about Peer Supported Collaborative Care for substance use and mental health disorders because it offers a comprehensive, team-based approach to treatment. Unlike standard treatments that often rely solely on medical professionals, this method includes peer case managers who provide ongoing support, making it more personalized and community-oriented. The approach integrates mental health and substance use disorder care directly into HIV primary care, utilizing motivational interviewing and evidence-based interventions, which could enhance patient engagement and adherence. This innovative model aims to improve outcomes by addressing both mental health and substance use disorders simultaneously and more holistically.
What evidence suggests that the Peer Supported Collaborative Care model is effective for integrating treatment for substance use and mental health disorders into HIV care settings?
Research has shown that the Peer Supported Collaborative Care model, which participants in this trial may receive, can enhance treatment for mental health and substance use issues. Studies have found that this approach improves access to mental health services and leads to better treatment outcomes. In this trial, the collaborative care team includes a peer case manager and an addiction psychiatrist who work together to support patients. This teamwork often results in improved mental health and substance use outcomes. With several professionals involved, patients receive more comprehensive care, which is linked to better health results.13456
Who Is on the Research Team?
Oluwaseun Falade-Nwulia, MD
Principal Investigator
Johns Hopkins School of Medicine
Are You a Good Fit for This Trial?
This trial is for adults aged 18-99 receiving HIV care who aren't currently treated for mental health or substance use disorders. They must speak English and have screened positive for these disorders at the Bartlett HIV clinic.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are assigned to either usual care or a peer-supported collaborative care model for mental health and substance use disorder treatment integrated into HIV care settings
Follow-up
Participants are monitored for changes in mental health and substance use disorder outcomes and HIV virologic suppression
What Are the Treatments Tested in This Trial?
Interventions
- Peer Supported Collaborative Care
Peer Supported Collaborative Care is already approved in United States for the following indications:
- Substance Use Disorders
- Mental Health Disorders
- HIV Care
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Collaborator